Molecular Diagnostics Market: Current Analysis and Forecast 2019-2025

$3500$6860

Emphasis on Product (Reagents, Instruments Services), Techniques (Polymerase Chain Reaction (PCR), Transcription-Mediated Amplification (TMA), In Situ Hybridization, DNA Sequencing & Next-Generation Sequencing (NGS), Chips and Microarrays, Others), Application (Microbiology, Virology, Hospital Acquired Infections (HAI), Genetic Testing, Oncology, Pharmacogenetics, Human Leukocytes Antigen (HLA), Blood Screening, Others), End-Users (Hospitals, Clinics & Labs, Other Healthcare Facilities) and Region/Country

Pages:

340

Table:

116

Figure:

216

Report ID:

UMHE19196

Geography:

Clear
  Get a Free Sample
SKU: UMHE19196 Category:
Report Description
Table of content
Research Methodology

Report Description

Global Molecular Diagnostics Market was valued at US$ 6,242.6 million in 2018 and is anticipated to reach US$ 9,546.2 million by 2025 displaying a reasonable CAGR of 6.3% over the forecast period (2019-2025). Molecular Diagnostics is the detection of genomic variants, aiming to facilitate detection, diagnosis, subclassification, prognosis, and monitoring response to therapy. The market of Molecular Diagnostics market is anticipated to grow enormously owing to factors such as rising geriatric population, increasing prevalence of chronic diseases, increasing adoption of Point-of-care diagnosisadvances in genomics and proteomics, and introduction of technologically advanced products. The growing incidence of infectious diseases and cancer is increasing the demand for molecular diagnostics techniques. The rapid advancements witnessed in the molecular biology technologies, development of molecular diagnostic technologies to automated processes, growing awareness about molecular diagnostics usage for the detection of different diseases in developing countries is boosting the overall market growth. The investment in unifying technology, consolidation and automation of labs, and shift to data-driven healthcare will mark as a trend in this industry. However, high prices of molecular diagnostics tests and unfavourable reimbursement policies will act as the major challenges in the growth of this market.

Points of Entry in the Diagnostics Supply Chain

In this evolving environment, it is a business imperative for diagnostic manufacturers to understand, demonstrate, and clearly articulate how their offerings can lead not only to better patient outcomes but also create value for a variety of key stakeholders. There are many ways that diagnostic technologies can impact the quality and cost of care. Medical diagnostic tests and technologies are at the forefront of health care and personalized medicine. These technologies increasingly are a key component in ensuring that the right treatment gets to the right patient at the right time. Advances in life sciences and in test technologies are making diagnostics ever more central in the delivery of effective health care. It is well understood by health care stakeholders that diagnostics significantly affect clinical decision-making. Nevertheless, it is critical for diagnostic test developers to be able to demonstrate the value of their tests to a variety of stakeholders in the face of growing scrutiny and cost pressure directed at almost every health care sector

“Reagents are the majorly used product under the Molecular Diagnostics market, holding ~69% share in 2018”

Based on product type the global molecular diagnostics market is bifurcated into Instruments, Reagents and services and others. The market of the Reagents segment is expected to grow tremendously and is projected to dominate the market in 2025 due to the high demand for over-the-counter diagnostic tests, rise in adoption of these tests in nonmedical facilities, such as home.

“Polymerase chain reaction (PCR) is expected to dominate the technique segment during the analyzed period.”

Molecular diagnostics market, based on technique is segmented into Polymerase Chain Reaction (PCR), Transcription-Mediated Amplification (TMA), In Situ Hybridization, DNA Sequencing & Next-Generation Sequencing (NGS), Chips and Microarrays and others. The PCR segment occupied the largest share and is expected to maintain its dominance throughout the forecast period 2019-2025 owing to the increased usage and advancements in PCR techniques.

Molecular Diagnostics Market Size by Technique Type, Global, 2018-2025 (US$ Million)

“Molecular Diagnostic techniques are majorly applied for Virology study, the segment generated revenue of US$ 2,243.9 million in 2018”

The molecular diagnostics market is applied in various medical fields including Microbiology, Virology, Hospital Acquired Infections (HAI), Genetic Testing, Oncology, Pharmacogenetics, Human Leukocytes Antigen (HLA), Blood Screening and others. In 2018, Virology segment dominated the market and is anticipated to dominate this segment in 2025. However, Oncology application segment is expected to witness the highest CAGR growth of 8.27% during the forecast period 2019-2025.

“Amongst end-users’ type, hospitals are anticipated to dominate Global Molecular Diagnostics market by 2025.”

Hospitals, clinics & labs and others are the major end-users of the molecular diagnostic technology. In 2018, the application of the technology was dominated by Hospitals segment. The increased adoption in hospitals is driven by high procedure volume and extensive presence of ancillary support in terms of manpower and infrastructure. However, Clinics & labs application type is expected to witness reasonable CAGR growth during the analyzed period.

“North America dominated the market for molecular diagnostic technology in 2018, followed by Asia-Pacific and Europe”

For a deep-dive analysis of the industry, detailed regional/country-level analysis is conducted for markets including North America (US, Canada, Rest of US), Europe (Germany, France, Spain, Italy, UK, Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of World (Brazil and Other Rest of World). In 2018, North America generated revenue of US$ 2,964.9 million, however, Asia-Pacific is expected to witness highest CAGR of 6.74% during the forecast period. The dominance of North America is majorly driven by the presence of a well-established diagnostic infrastructure, technological advancements, patient awareness and presence of advanced products in the field of molecular diagnostics.

Competitive Landscape-Top 10 Market Players

Abbott Laboratories, Becton Dickinson and Company, Biomerieux SA, Danaher Corporation, Hologic, Inc., Qiagen, Roche, Siemens Healthineers AG, Sysmex Corporation and Thermo Fisher Scientific are some of the prominent players operating in the Global Molecular Diagnostics market industry. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products.

Reasons to buy:

  • Current and future market size from 2018 to 2025 in terms of value (US$)
  • Combined analysis of deep-dive secondary research and input from primary research through Key Opinion Leaders of the industry
  • Country-level details of the overall adoption of molecular diagnostics market
  • A quick review of overall industry performance at a glance
  • In-depth analysis of key industry players
  • A detailed analysis of regulatory framework, drivers, restraints, key trends and opportunities prevailing in the industry
  • Examination of industry attractiveness with the help of Porter’s Five Forces analysis and start-ups
  • The study comprehensively covers the market across different segments and sub-segments of the technology
  • Regions/countries Covered: North America (US, Canada, Rest of US), Europe (Germany, France, Spain, Italy, UK, Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of World (Brazil and Other Rest of World)

Customization Options:

UMI understands that you may have your own business need, hence we also provide fully customized solutions to clients. The Global Molecular Diagnostics Market can be customized to the country level or any other market segment.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

  1.1Market Definition 
  1.2Objective of the Study
  1.3Limitation   
  1.4Stakeholders  
  1.5Currency used in the Report
  1.6Scope of the Global Molecular Diagnostics Market Study

 

  2.1Research Methodology for Global Molecular Diagnostics (MDx) Market Study
   2.1.1Main objective of the Global Molecular Diagnostics Market Study
  3.1General Overview 
  3.2Capturing the full spectrum of the value that a diagnostic test contributes
  3.3Ensuring that robust analyses underpin the value assessment
  3.4Accounting for variation in diagnostic test types in value assessment methods
  3.5Aligning on how to define and measure value drivers
   3.5.1Value Driver: Clinical Impact
   3.5.2Value Driver: Non-Clinical Patient Impact
   3.5.3Value Driver: Care Delivery Revenue and Cost Impact
   3.5.4Value Driver: Public/Population Impact
 4.1General Overview
  7.1General Overview 
  7.2Supply Chain  
  7.3Risk Assessment 
  7.4Bulk, Custom and Contract Manufacturing
  5.1Introduction of Molecular Diagnostics Market
   5.1.1Essential Components or Attributes of Diagnostics
   5.1.2Main Categories of Diagnostics
   5.1.3Settings of Use 
  5.2Current and Future Use of Diagnostic Products
   5.2.1Primary Uses of Diagnostics
    5.2.1.1Predictive Applications/Screening/Early Disease Detection
    5.2.1.2Diagnostic
    5.2.1.3Secondary Risk Assessment – Prognostic
    5.2.1.4Drug Selection/Treatment Targeting
    5.2.1.5Disease/Condition Monitoring and Management
   5.2.2Molecular Diagnostics: Overview of Future Trends and Directions
    5.2.2.1Predict Disease Before Symptoms Appear
    5.2.2.2Predict Beneficial and Adverse Treatment Effects
    5.2.2.3Enable Personalized “Real-Time” Treatment and Disease Management Regimens
    5.2.2.4Facilitate Point-of-care and Near-patient Testing
    5.2.2.5Enable Home Testing
    5.2.2.6Public Health, Environmental, Bioterrorism Applications
    5.2.2.7Technology and Testing System Integration
   5.2.3The Importance of Molecular Diagnostics
   5.2.4Market Drivers 
    5.2.4.1Increasing Prevalence of Chronic Diseases
    5.2.4.2Rising Geriatric Population
    5.2.4.3Increasing adoption of Point-of-Care Diagnosis
    5.2.4.4Technology Advancement in the In-Vitro Diagnostics
    5.2.4.5Advances in Genomics and Proteomics
   5.2.5Market Restraints
    5.2.5.1Unfavorable Reimbursement Policies for In-Vitro Diagnostics
    5.2.5.2High Prices of Molecular Diagnostics Tests
   5.2.6Market Opportunities
    5.2.6.1Increasing Support from Governments and Key Players
    5.2.6.2Growing Significance of Companion Diagnostics
   5.2.7Market Trends 
    5.2.7.1Changing Reimbursement Models and Regulations
    5.2.7.2Investing in Unifying Technology
    5.2.7.3Consolidation and Automation of Labs
    5.2.7.4Shift to Data-Driven Healthcare
    5.2.7.5Consumer Lab Testing
    5.2.7.6Healthcare Convergence
  6.1Regulation  
   6.1.1United States 
    6.1.1.1Approval/Clearance of Molecular Diagnostic Instruments
    6.1.1.2Recommendations for Submissions for Molecular Diagnostic Instruments with Combined Functions
     6.1.1.2.1New Instruments
     6.1.1.2.2Existing Approved/Cleared Instruments
     6.1.1.2.3Submission Information, Labeling, and Marketing
     6.1.1.2.4Promotion and Labeling Issues
     6.1.1.2.5Software/Hardware Changes
     6.1.1.2.6Third-Party Assay Developers
     6.1.1.2.7MDR Reporting
  6.2Reimbursemen
  7.1Demand Side Analysis
   7.1.1Some of the Key Facts about Aging Population
   7.1.2Health Conditions Associated with Aging
    7.1.2.1Some of the key facts about Cardiovascular Diseases (CVD) as per WHO
  7.2Supply Side Analysis 
   7.2.1Product Launches
   7.2.2Partnership 
   7.2.3Business Expansions and Investments
   7.2.4Merger and Acquisition
  7.3SWOT Analysis of Molecular Diagnostics
  7.4Value Chain Analysis of Molecular Diagnostics

 

  8.1General Overview 
   8.1.1Reagents  
   8.1.2Instruments Services

 

  9.1General Overview 
   9.1.1Polymerase chain reaction (PCR)
   9.1.2Transcription-Mediated Amplification (TMA)
   9.1.3In Situ Hybridization & FISH
   9.1.4DNA Sequencing & Next-Generation Sequencing (NGS)
   9.1.5Case Study: Next Generation Sequencing for Clinical Diagnostics
   9.1.6Chips and Microarrays
   9.1.7Others
  10.1General Overview 
   10.1.1Microbiology 
   10.1.2Virology  
   10.1.3Hospital Acquired Infections (HAI)
   10.1.4Genetic Testing 
   10.1.5Oncology  
   10.1.6Pharmacogenetics
   10.1.7Human Leukocyte Antigen (HLA Testing)
   10.1.8Blood Screening
   10.1.9Others

 

  11.1General Overview 
   11.1.1Hospitals  
   11.1.2Clinics & Laboratory
   11.1.3Others

 

  12.1General Overview 
   12.2North America MDx Market Insight
    12.2.1North America Molecular Diagnostics Market by Product
    12.2.2North America Molecular Diagnostics Market by Technique
    12.2.3North America Molecular Diagnostics Market by Application
    12.2.4North America Molecular Diagnostics Market by End Users
    12.2.5North America Molecular Diagnostics Market by Country
     12.2.5.1United States
      12.2.5.1.1Key Findings on Healthcare Spending in the US, 2017
      12.2.5.1.2US Health Spending by Type of Service or Product, 2017
      12.2.5.1.3Health Spending by Major Sources of Funds
      12.2.5.1.4United States Molecular Diagnostics Market by Product
      12.2.5.1.5United States Molecular Diagnostics Market by Technique
      12.2.5.1.6United States Molecular Diagnostics Market by Application
      12.2.5.1.7United States Molecular Diagnostics Market by End Users
     12.2.5.2Canada
      12.2.5.2.1Key Findings on Canada Healthcare Spending, 2018
      12.2.5.2.2Key Findings on Hospital sector Spending in Canada, 2017
      12.2.5.2.3Canada Molecular Diagnostics Market by Product
      12.2.5.2.4Canada Molecular Diagnostics Market by Technique
      12.2.5.2.5Canada Molecular Diagnostics Market by Application
      12.2.5.2.6Canada Molecular Diagnostics Market by End Users
     12.2.5.5Rest of North America
      12.2.5.5.1Rest of NA Molecular Diagnostics Market by Product
      12.2.5.5.2Rest of NA Molecular Diagnostics Market by Technique
      12.2.5.5.3Rest of NA Molecular Diagnostics Market by Application
      12.2.5.5.4Rest of NA Molecular Diagnostics Market by End Users
  12.3Europe Molecular Diagnostic Market Insight
   12.3.1Europe Molecular Diagnostics Market by Product
   12.3.2Europe Molecular Diagnostics Market by Technique
   12.3.3Europe Molecular Diagnostics Market by Application
   12.3.4Europe Molecular Diagnostics Market by End Users
   12.3.5Europe Molecular Diagnostics Market by Country
    12.3.5.1Germany 
     12.3.5.1.1Germany Molecular Diagnostics Market by Product
     12.3.5.1.2Germany Molecular Diagnostics Market by Technique
     12.3.5.1.3Germany Molecular Diagnostics Market by Application
     12.3.5.1.4Germany Molecular Diagnostics Market by End Users
    12.3.5.2France 
     12.3.5.2.1France Molecular Diagnostics Market by Product
     12.3.5.2.2France Molecular Diagnostics Market by Technique
     12.3.5.2.3France Molecular Diagnostics Market by Application
     12.3.5.2.4France Molecular Diagnostics Market by End Users
    12.3.5.3Spain 
     12.3.5.3.1Spain Molecular Diagnostics Market by Product
     12.3.5.3.2Spain Molecular Diagnostics Market by Technique
     12.3.5.3.3Spain Molecular Diagnostics Market by Application
     12.3.5.3.4Spain Molecular Diagnostics Market by End Users
    12.3.5.4Italy  
     12.3.5.4.1Italy Molecular Diagnostics Market by Product
     12.3.5.4.2Italy Molecular Diagnostics Market by Technique
     12.3.5.4.3Italy Molecular Diagnostics Market by Application
     12.3.5.4.4Italy Molecular Diagnostics Market by End Users
    12.3.5.5United Kingdom
     12.3.5.5.1United Kingdom Molecular Diagnostics Market by Product
     12.3.5.5.2United Kingdom Molecular Diagnostics Market by Technique
     12.3.5.5.3United Kingdom Molecular Diagnostics Market by Application
     12.3.5.5.4United Kingdom Molecular Diagnostics Market by End Users
    12.3.5.6Rest of Europe
     12.3.5.6.1Rest of Europe Molecular Diagnostics Market by Product
     12.3.5.6.2Rest of Europe Molecular Diagnostics Market by Technique
     12.3.5.6.3Rest of Europe Molecular Diagnostics Market by Application
     12.3.5.6.4Rest of Europe Molecular Diagnostics Market by End Users
  12.4Asia-Pacific Molecular Diagnostics Market Insight
   12.4.1Asia-Pacific Molecular Diagnostics Market by Product
   12.4.2Asia-Pacific Molecular Diagnostics Market by Technique
   12.4.3Asia-Pacific Molecular Diagnostics Market by Application
   12.4.4Asia-Pacific Molecular Diagnostics Market by End Users
   12.4.5Asia-Pacific Molecular Diagnostics Market by Country
    12.4.5.1China 
     12.4.5.1.1China In-Vitro Diagnostics Services Market
     12.4.5.1.2China Molecular Diagnostics Market by Product
     12.4.5.1.3China Molecular Diagnostics Market by Technique
     12.4.5.1.4China Molecular Diagnostics Market by Application
     12.4.5.1.5China Molecular Diagnostics Market by End Users
    12.4.5.2India 
     12.4.5.2.1India Molecular Diagnostics Market by Product
     12.4.5.2.2India Molecular Diagnostics Market by Technique
     12.4.5.2.3India Molecular Diagnostics Market by Application
     12.4.5.2.4India Molecular Diagnostics Market by End Users
    12.4.5.3Japan 
     12.4.5.3.1Japan Molecular Diagnostics Market by Product
     12.4.5.3.2Japan Molecular Diagnostics Market by Technique
     12.4.5.3.3Japan Molecular Diagnostics Market by Application
     12.4.5.3.4Japan Molecular Diagnostics Market by End Users
    12.4.5.4Australia 
     12.4.5.4.1Australia Molecular Diagnostics Market by Product
     12.4.5.4.2Australia Molecular Diagnostics Market by Technique
     12.4.5.4.3Australia Molecular Diagnostics Market by Application
     12.4.5.4.4Australia Molecular Diagnostics Market by End Users
    12.4.5.5Rest of APAC Market Insight
     12.4.5.5.1Rest of APAC Molecular Diagnostics Market by Product
     12.4.5.5.2Rest of APAC Molecular Diagnostics Market by Technique
     12.4.5.5.3Rest of APAC Molecular Diagnostics Market by Application
     12.4.5.5.4Rest of APAC Molecular Diagnostics Market by End Users
  12.5Rest of World Market Insight
   12.5.1Rest of World Molecular Diagnostics Market by Product
   12.5.2Rest of World Molecular Diagnostics Market by Technique
   12.5.3Rest of World Molecular Diagnostics Market by Application
   12.5.4Rest of World Molecular Diagnostics Market by End Users
   12.5.5Rest of World Molecular Diagnostics Market by Country
    12.5.5.1Brazil 
     12.5.5.1.1Brazil Molecular Diagnostics Market by Product
     12.5.5.1.2Brazil Molecular Diagnostics Market by Technique
     12.5.5.1.3Brazil Molecular Diagnostics Market by Application
     12.5.5.1.4Brazil Molecular Diagnostics Market by End Users
    12.5.5.2Other Rest of World
     12.5.5.2.1Other Rest of World Molecular Diagnostics Market by Product
     12.5.5.2.2Other Rest of World Molecular Diagnostics Market by Technique
     12.5.5.2.3Other Rest of World Molecular Diagnostics Market by Application
     12.5.5.2.4Other Rest of World Molecular Diagnostics Market by End Users
  13.1Porter’s Five forces analysis
   13.1.1Bargaining Power of Suppliers
   13.1.2Bargaining Power of Buyers
   13.1.3Threat of New Entrants
   13.1.4Threat of Substitutes
   13.1.5Industry Rivalry 
  13.2Market Share Analysis, by Company
   13.2.1Molecular Diagnostics Market Share Analysis by Company 2018
  14.1Abbott Laboratories 
   14.1.1Key Facts  
   14.1.2Business Description
   14.1.3Key Product/Services Offerings
   14.1.4Growth Strategy
   14.1.5SWOT Analysis 
   14.1.6Key Financials 
    14.1.6.1Revenue Split
   14.1.7Recent Developments
    14.1.7.1Product Launches
    14.1.7.2Partnership
    14.1.7.3Merger and Acquisition
  14.2Becton, Dickinson and Company
   14.2.1Key Facts  
   14.2.2Business Description
   14.2.3Key Product/Services Offerings (AI Technology)
   14.2.4Growth Strategy
   14.2.5SWOT Analysis 
   14.2.6Key Financials 
    14.2.6.1Revenue Split
   14.2.7Recent Developments
    14.2.7.1Product Launches
    14.2.7.2Business Expansions and Investments
    14.2.7.3Merger & Acquisitions
  14.3Biomérieux SA  
   14.3.1Key Facts  
   14.3.2Business Description
   14.3.3Key Product/Services Offerings
   14.3.4Growth Strategy
   14.3.5SWOT Analysis 
   14.3.6Key Financials 
    14.3.6.1Revenue Split
   14.3.7Recent Developments
    14.3.7.1Product Launches
    14.3.7.2Partnerships
    14.3.7.3Mergers and Acquisitions
  14.4Hologic, Inc.  
   14.4.1Key Facts  
   14.4.2Business Description
   14.4.3Key Product/Services Offerings
   14.4.4Growth Strategy
   14.4.5SWOT Analysis 
   14.4.6Key Financials 
    14.4.6.1Revenue Split
   14.4.7Recent Developments
    14.4.7.1Product Launches
    14.4.7.2Partnerships
    14.4.7.3Business Expansion & Investment
    14.4.7.4Mergers and Acquisitions
  14.5Danaher Corporation 
   14.5.1Key Facts  
   14.5.2Business Description
   14.5.3Key Product/Services Offerings
   14.5.4Growth Strategy
   14.5.5SWOT Analysis 
   14.5.6Key Financials 
    14.5.6.1Revenue Split
   14.5.7Recent Developments
    14.5.7.1Merger and Acquisitions
  14.6Qiagen   
   14.6.1Key Facts  
   14.6.2Business Description
   14.6.3Key Product/Services Offerings
   14.6.4Growth Strategy
   14.6.5Key Milestones 
   14.6.6SWOT Analysis 
   14.6.7Key Financials 
    14.6.7.1Revenue Split
   14.6.8Recent Developments
    14.6.8.1Product Launches
    14.6.8.2Partnerships
    14.6.8.3Business Expansions and Investment
    14.6.8.4Mergers and Acquisitions
  14.7Roche Holding AG 
   14.7.1Key Facts  
   14.7.2Business Description
   14.7.3Key Product/Services Offerings
   14.7.4Growth Strategy
   14.7.5SWOT Analysis 
   14.7.6Key Financials 
    14.7.6.1Revenue Split
   14.7.7Recent Developments
    14.7.7.1Product Launches
    14.7.7.2Partnership
    14.7.7.3Mergers and Acquisitions
  14.8Siemens Healthineers AG
   14.8.1Key Facts  
   14.8.2Business Description
   14.8.3Key Product/Services Offerings
   14.8.4Growth Strategy
   14.8.5SWOT Analysis 
   14.8.6Key Financials 
    14.8.6.1Revenue Split
   14.8.7Recent Developments
    14.8.7.1Product Launches
    14.8.7.2Partnership
    14.8.7.3Business Expansion and Investment
    14.8.7.4Merger and Acquisitions
  14.9Thermo Fisher Scientific
   14.9.1Key Facts  
   14.9.2Business Description
   14.9.3Key Product/Services Offerings
   14.9.4Growth Strategy
   14.9.5SWOT Analysis 
   14.9.6Key Financials 
    14.9.6.1Revenue Split
   14.9.7Recent Developments
    14.9.7.1Product Launch
    14.9.7.2Partnerships
    14.9.7.3Expansion and Investment
    14.9.7.4Merger and Acquisition
  14.1Sysmex Corporation 
   14.10.1Key Facts  
   14.10.2Business Description
   14.10.3Key Product/Services Offerings
   14.10.4Growth Strategy
   14.10.5SWOT Analysis 
   14.10.6Key Financials 
    14.10.6.1Revenue Split
   14.10.7Recent Developments
    14.10.7.1Product Launches
    14.10.7.2Partnership
    14.10.7.3Business Expansion & Investments
    14.10.7.4Merger and Acquisitions
  18.1Intuitive Surgical
   18.1.1Key Facts 
   18.1.2Business Description
   18.1.3Key Product/Services Offerings
   18.1.4SWOT Analysis
   18.1.5Key Financials
    18.1.5.1Revenue Split, by Region and Segment
   18.1.6Recent Developments
  18.2Zimmer Biomet 
   18.2.1Key Facts 
   18.2.2Business Description
   18.2.3Key Product/Services Offerings
   18.2.4SWOT Analysis
   18.2.5Key Financials
    18.2.5.1Revenue Split, by Region and Segment
   18.2.6Recent Developments
  18.3Mazor Robotics 
   18.3.1Key Facts 
   18.3.2Business Description
   18.3.3Key Product/Services Offerings
   18.3.4SWOT Analysis
   18.3.5Key Financials
    18.3.5.1Revenue Split, by Region and Segment
   18.3.6Recent Developments
  18.4Accuray Inc. 
   18.4.1Key Facts 
   18.4.2Business Description
   18.4.3Key Product/Services Offerings
   18.4.4SWOT Analysis
   18.4.5Key Financials
    18.4.5.1Revenue Split, by Region and Segment
   18.4.6Recent Developments
  18.5Auris Health 
   18.5.1Key Facts 
   18.5.2Business Description
   18.5.3Key Product/Services Offerings
   18.5.4SWOT Analysis
   18.5.5Recent Developments
  18.6Toyota Industries Corporation
   18.6.1Key Facts 
   18.6.2Business Description
   18.6.3Key Product/Services Offerings
   18.6.4SWOT Analysis
   18.6.5Key Financials
    18.6.5.1Revenue Split
   18.6.6Recent Developments
  18.7Hitachi Healthcare Manufacturing, Ltd.
   18.7.1Key Facts 
   18.7.2Business Description
   18.7.3Key Product/Services Offerings
   18.7.4SWOT Analysis
   18.7.5Recent Developments
  18.8Stryker Corporation
   18.8.1Key Facts 
   18.8.2Business Description
   18.8.3Key Product/Services Offerings
   18.8.4SWOT Analysis
   18.8.5Key Financials
    18.8.5.1Revenue Split
   18.8.6Recent Developments
  18.9Panasonic Corporation
   18.9.1Key Facts 
   18.9.2Business Description
   18.9.3Key Product/Services Offerings
   18.9.4SWOT Analysis
   18.9.5Key Financials
    18.9.5.1Revenue Split
   18.9.6Recent Developments
  18.10Fujitsu, Ltd. 
   18.10.1Key Facts 
   18.10.2Business Description
   18.10.3Key Product/Services Offerings
   18.10.4SWOT Analysis
   18.10.5Key Financials
    18.10.5.1Revenue Split
   18.10.6Recent Developments

Research Methodology

Analyzing historical market, estimation of the current market and forecasting the future market for Global Molecular Diagnostics were the three major steps undertaken to create and analyze the overall adoption rate of Molecular Diagnostics services in major regions/countries globally. Exhaustive secondary research was conducted to collect the historical market of the technology and overall estimation of the current market. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were conducted with industry experts across value chain of the Molecular Diagnostics. Post assumption and validation of market numbers through primary interviews, top-down approach was employed to forecast the complete market size of Molecular Diagnostics market at Global scale. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the current and forecast market size of segments and sub-segments of the technology. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the Global Molecular Diagnostics Market through company internal sources such as annual report & financial statements, performance presentations, press releases, inventory records, etc. and external sources including trade journals, news & articles, government publications, economic data, competitor publications, sector reports, regulatory bodies publications, safety standard organizations, third-party database and other credible publicationsFor economic data collection, sources such as World Bank, CDC, European Commission (EC), United Nations and WHO, OECD among others were used.

Step 2: Market Segmentation:

After obtaining the historical market size of the overall market, detailed secondary analysis was conducted to gather historical market insights and share for different segments and sub-segments of the Global Molecular Diagnostics. Major segments included in the report are product type, technique, application and end-users. Further detailed regional/country-level analysis was also conducted to analyze the overall penetration rate of the technology

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments detailed factor analysis was conducted to estimate the current market size of the Global Molecular Diagnostics. Factor analysis was conducted using dependent and independent variables such as accelerating aging population, rising prevalence of age-related disorders and Increasing demand for residential care facilities. Historical trends of the Global Molecular Diagnostics and their year-on-year impact on the market size and share in the recent past were analyzed. The demand and supply-side scenario were also thoroughly studied.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at current market size, key players in major applications and markets, market shares of these players and industry’s supply chain. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weightage was assigned to different factors including market drivers, restraints, trends and opportunities available in the market. After analyzing these factors, relevant forecasting techniques i.e. Bottom-up/Top-down was applied to arrive at the market forecast pertaining to 2025 for different segments and sub-segments for major regions/countries. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value and rate of adoption of Molecular Diagnostics technique globally
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in major applications and markets as well as the market share of each player. Also, the growth strategies adopted by these players to compete in the ever-growing Global Molecular Diagnostics market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, etc.). Primary research findings were summarized, and statistical analysis was performed to prove the stated hypothesis. Input from primary research was consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants

Market Engineering

Data triangulation technique was employed to complete the overall market engineering process and to arrive at precise statistical numbers of each segment and sub-segment pertaining to the Global Molecular Diagnostics market. Data was split into several segments post studying various parameters and trends in the areas of product type, technique such as Polymerase Chain Reaction (PCR), Transcription-Mediated Amplification (TMA), In Situ Hybridization & FISH, DNA Sequencing & Next-Generation Sequencing (NGS), Chips and Microarrays and applications and regions such as North America, Europe, APAC among others

Main objective of the Global Molecular Diagnostics Market Study

The current & future market trends of the global Molecular Diagnostics market are pinpointed in the study. The investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. The current and future market trends would determine the overall attractiveness of the market, providing a platform for the diagnostics healthcare participant to exploit the untapped market to benefit as the first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of the global Molecular Diagnostics market in terms of value (US$) and volume
  • Analyze the current and forecast market size of different segments and sub-segments of the global Molecular Diagnostics market
  • To analyze the revenue and business models of the market players in the industry
  • To understand the initiatives undertaken by diagnostics companies Vs service providers to increase the overall analysis of Molecular Diagnostics in major regions
  • Define and describe the segments and sub-segments considered in the evaluation of the global Molecular Diagnostics market and anticipate potential risk associated with the market
  • Define and analysis of the government regulations for diagnostics
  • Analyze the current and forecast market size of the global Molecular Diagnostics market for major regions/countries including North America (US, Canada, Rest of US), Europe (Germany, France, Spain, Italy, UK, Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of World (Brazil and Other Rest of World)

Define and analyze the competitive landscape of the global Molecular Diagnostics market and the growth strategies adopted by the market players to sustain in the fast-growing market